Cormorant Asset Management LP

-

Director Information, Funds, Firms

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cormorant Asset Management LP
FirmCormorant Asset Management LP
Address200 Clarendon Street 52nd Floor
Boston, MA 02116
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM
Cormorant Asset Management LP
Cormorant Private Healthcare Fund VI LP 021-565060 Executive Officer
75.2 M
of 400.0 M
102.9 M
Cormorant Private Healthcare Fund V LP 021-489172 Executive Officer
318.0 M
of 318.0 M
491.7 M
Cormorant Private Healthcare Fund IV LP 021-408560 Executive Officer
252.7 M
of 400.0 M
426.3 M
Cormorant Private Healthcare Fund III LP 021-370919 Executive Officer
206.3 M
of 419.9 M
429.5 M
Cormorant Private Healthcare Fund II LP 021-319526 Promoter
105.5 M
of 350.0 M
125.2 M
Cormorant Global Healthcare Master Fund LP 021-196566 Executive Officer
589.2 M 2.2 B
Cormorant Private Healthcare Offshore Fund VI LP 021-565061 Executive Officer
13.6 M
of 400.0 M
Cormorant Private Healthcare Offshore Fund V LP 021-489177 Executive Officer
119.0 M
of 119.0 M
Cormorant Private Healthcare Offshore Fund IV LP 021-408561 Executive Officer
69.2 M
of 400.0 M
Cormorant Private Healthcare Offshore Fund III LP 021-370920 Executive Officer
213.7 M
of 419.9 M
Cormorant Private Healthcare Offshore Fund II LP 021-319527 Promoter
93.2 M
of 350.0 M
Cormorant Global Healthcare Fund LP 021-196564 Executive Officer
637.0 M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
SAV Acquisition Corp CRBP
Common Stock
2025-12-11 Sell 30,029 $11.46 344,132
EyePoint Inc EYPT
Common Stock
2025-12-04 Sell 60,000 $15.70 942,000
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-30 Sell 5,827 $6.96 40,556
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 2,800,000 $6.61 18,508,000
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 3,390,943 $7.58 25,703,348
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 232,460 $8.40 1,952,664
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 70,748 $9.38 663,616
Biomea Fusion Inc BMEA
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 91,970 $0.00
OnKure Therapeutics Inc OKUR
Class A Common Stock
2025-05-15 Sell 1,813,439 $1.85 3,354,862
OnKure Therapeutics Inc OKUR
Class A Common Stock
2025-05-12 Sell 24,300 $1.99 48,357
Aardvark Therapeutics Inc AARD
Series C Convertible Preferred Stock · derivative
2025-02-14 Conversion 6,780,810
Aardvark Therapeutics Inc AARD
Common Stock
2025-02-14 Buy 187,500 $16.00 3,000,000
Aardvark Therapeutics Inc AARD
Common Stock
2025-02-14 Conversion 800,189
Bright Minds Biosciences Inc DRUG
Common Shares
2024-11-04 Buy 184,331 $21.70 3,999,983
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-16 Buy 7,150 $24.03 171,814
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-16 Buy 39,743 $23.22 922,832
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-16 Buy 3,107 $25.22 78,359
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 63,173 $5.92 373,984
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 33,343 $6.42 214,062
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 8,900 $7.31 65,059
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com